APPLICATIONS
Product Type: HuSu-Trans-MSC
Quantifiables:
Apoptosis, Necrosis, Vacuolization, inflammatory Interleukins, LD50, Delayed-type hypersensitivity (DTH), mitogen-or antigen-stimulated lymphocyte proliferative responses, macrophage function, and primary antibody response to T-cell dependent antigen, alteration in proto-oncogenes of tumor suppressor gene mutation, gene mutations, pluripotency, multipotency, bipotency, unipotency, tumor inducing property, stem cell DNA damage, stem cell mutation, inflammatory cascade, tumor formation, drug distribution ratio
Compatible Assays
Acute mammalian toxicity
Chronic toxicity
Cell penetration tests
Receptor binding tests
Eye/Skin corrosion tests
Cytotoxicity/Cell function based invitro tests
Genotoxicity tests
Developmental toxicity tests
Potency tests
Relevance
Contract Research Organizations
Toxicity testing labs
Pharma
Biotech R&D
Product Type: HuSu-Trans-HSC
Quantifiables:
Hematotoxicity specific Colony Forming Units (of hematopoietic precursor cells of various types), Spreading properties of platelets, Blood cell metabolic or functional changes and their dose response relationships, Development of micronuclei, Of any chromosomal aberrations
Compatible Assays
Hematotoxicity tests
Pyrogenicity tests
Relevance
Contract Research Organizations
Toxicity testing labs
Pharma
Biotech R&D
Product Type: HuSu-Trans-TR-B
Quantifiables:
Breast cancer cells specific death, cell signalling related proto-genomics, Tumor shrinking tests, Patient derived xenografts (PDX)
Compatible Assays
N/A
Relevance
Contract Research Organizations
Pharma in Oncology R&D
Product Type: HuSu-Trans-TR-H&N
Quantifiables:
Head & Neck cancer cells specific death, cell signalling related proto-genomics, Tumor shrinking tests, Patient derived xenografts (PDX)
Compatible Assays
N/A
Relevance
Contract Research Organizations
Pharma in Oncology R&D
Product Type: HuSu-Trans-TR-C
Quantifiables:
Colon cancer cells specific death, cell signalling related proto-genomics, Tumor shrinking tests, Patient derived xenografts (PDX)
Compatible Assays
N/A
Relevance
Contract Research Organizations
Pharma in Oncology R&D
Product Type: HuSu-Trans-TR-O
Quantifiables:
Ovarian cancer cells specific death, cell signalling related proto-genomics, Tumor shrinking tests, Patient derived xenografts (PDX)
Compatible Assays
N/A
Relevance
Contract Research Organizations
Pharma in Oncology R&D
Product Type: HuSu-Transchymal™-UC
Quantifiables:
To build 3D organs, human tissue (trachea, heart, liver, bone) engineering
Compatible Assays
N/A
Relevance
3D Bioprinting companies
Biotechs in Tissue engineering
Exosomes research companies
Product Type: HuSu-Transchymal™-DP
Quantifiables:
To build 3D neural network, 3D periodontum, 3D tooth, cornea
Compatible Assays
N/A
Relevance
3D Bioprinting companies
Biotechs in Tissue engineering
Exosomes research companies
Product Type: HuSu-Transchymal™-AD
Quantifiables:
To build 3D breast
Compatible Assays
N/A
Relevance
3D Bioprinting companies
Biotechs in Tissue engineering
Exosomes research companies
Product Type: HuSu-TRANSKIN
Quantifiables:
Phenotype , Genotype test end points on Human Skin tissue model
Compatible Assays
Reliability Test, Residual Antibacterial Test,Invitro Skin Substrate Assay
Relevance
Cosmetic Testing Labs
Product Type: HuSu-Trans-TT
Quantifiables:
Invitro Phenotype, Genotype & Proteomics assay end points in Oncology Drug discovery
Compatible Assays
Spheroid Assay, Invitro Toxicity Tests, Invitro Preclinical Exploratory Research in Oncology
Relevance
Drug Discovery in Oncology